Could GLP-1 Drugs Help Us Live Longer? New Study Shows Promise
A new animal-based study has found GLP-1s could have the potential to do more than curb appetite—they may even extend life span.
A recent study from the University of California, Berkeley has found that GLP-1 drugs, commonly known as weight loss medications like Ozempic and Wegovy, may have the potential to extend human life span. The animal-based research involved treating female mice with semaglutide, a GLP-1 receptor agonist, and discovered that the mice lived longer, around 834 days compared to the control group's 742 days.
The study, published in Nature, suggests that the drugs could be used not only to treat obesity and type 2 diabetes but also to slow aging and promote longevity. GLP-1s work by suppressing appetite and regulating blood sugar levels, which could explain the extended lifespan. However, experts caution that translating these findings to humans is complex due to the differences between mice and humans, and safety is a primary concern, especially for promoting longevity in healthy individuals.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
